Search - tctmd.com

Displaying 61 - 80 of 304

Sort: Relevancy | Date

Presentation TCT 2024

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 257: Impact of Diabetes on Coronary Artery Disease Patterns and PCI Outcomes

Presenter: Koshiro Sakai

October 30, 2024

Presentation TCT 2024

GLP1 Agonists, the Promise of SELECT and Implications for Diabetes Drugs in PCI Patients

Presenter: Donna Lin

October 29, 2024

Presentation TCT 2024

Diabetes and Obesity: Modulating Cardiometabolic Risks

Presenter: C. Michael Gibson

October 28, 2024

Presentation TCT 2024

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Presenter: Daria Feshchenko

October 28, 2024

Presentation TCT 2024

TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

Presenter: Gakuto Bando

October 28, 2024

Presentation TCT 2024

GDMT for PAD to Include Diabetes and Nutrition

Presenter: Bailey Estes

October 27, 2024

Presentation TCT 2024

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

Presenter: Sant Kumar

October 27, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

Presenter: Giulio Stefanini

October 26, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 521: Comparison of 3-year outcomes between patients with acute myocardial infarction, nonobstructive coronary arteries, and diabetes versus non-diabetes

Presenter: Ae-Young Her

October 25, 2023

Advertisement

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

TCT 257: Impact of Diabetes on Coronary Artery Disease Patterns and PCI Outcomes

GLP1 Agonists, the Promise of SELECT and Implications for Diabetes Drugs in PCI Patients

Diabetes and Obesity: Modulating Cardiometabolic Risks

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

TCT 446: Long-term Outcomes and Impact of Diabetes Mellitus in Patients Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis

GDMT for PAD to Include Diabetes and Nutrition

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Main Results From The Step-hfpef Dm Trial

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Dapagliflozin in myocardial infarction without diabetes or heart failure

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 521: Comparison of 3-year outcomes between patients with acute myocardial infarction, nonobstructive coronary arteries, and diabetes versus non-diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content